Search Results - "Haas, Angela"

Race, Rhetoric, and Technology: A Case Study of Decolonial Technical Communication Theory, Methodology, and Pedagogy by Haas, Angela M.

“…This article engages disciplinary (and interdisciplinary) conversations at the intersections of race, rhetoric, technology, and technical communication and…”
Get full text

Recognition and Management of Feeding Dysfunction in the Pediatric Patient with Eosinophilic Esophagitis by Haas, Angela M., Doidge, Rebecca J., Hiremath, Girish

“…Feeding is a complex skill requiring coordination of multiple body systems. Multiple factors are considered in feeding dysfunction in pediatric patients with…”
Get full text

Medical Marvels and Professional Medicine: Establishing Scientific Authority in Enlightenment France by Haas, Angela C

“…Summary This article examines the investigation of medical marvels—principally reported cases of human bodies that could spontaneously produce rocks, needles,…”
Get full text

Long‐term safety and efficacy of filgotinib for the treatment of moderately to severely active ulcerative colitis: Interim analysis from up to 4 years of follow‐up in the SELECTION open‐label long‐term extension study by Feagan, Brian G., Matsuoka, Katsuyoshi, Rogler, Gerhard, Laharie, David, Vermeire, Séverine, Danese, Silvio, Loftus, Edward V., Beales, Ian, Schreiber, Stefan, Kim, Hyo Jong, Faes, Margaux, Haas, Angela, Masior, Tomasz, Rudolph, Christine, Peyrin‐Biroulet, Laurent

“…Summary Background Filgotinib, an oral, once‐daily, Janus kinase 1 preferential inhibitor, is an approved treatment for moderately to severely active…”
Get full text

Nutritional State and Feeding Behaviors of Children With Eosinophilic Esophagitis and Gastroesophageal Reflux Disease by Mehta, Pooja, Furuta, Glenn T., Brennan, Taryn, Henry, Michelle L., Maune, Nancy Creskoff, Sundaram, Shikha S., Menard‐Katcher, Calies, Atkins, Dan, Takurukura, Faith, Giffen, Sandra, Pan, Zhaoxing, Haas, Angela M.

“…ABSTRACT Objective: As both gastroesophageal reflux disease (GERD) and eosinophilic esophagitis (EoE) are associated with malnutrition and feeding dysfunction,…”
Get full text

Wampum as Hypertext: An American Indian Intellectual Tradition of Multimedia Theory and Practice by HAAS, ANGELA M.

“…Dating back one thousand years, wampum and other material components (e.g., bark fibers, sinew, hemp fibers, string-or other weaving materials) have been used…”
Get full text

Significance of feeding dysfunction in eosinophilic esophagitis by Menard-Katcher, Calies, Henry, Michelle, Furuta, Glenn T, Atkins, Dan, Maune, Nancy Creskoff, Haas, Angela M

“…Feeding dysfunction is a frequent presenting symptom of eosinophilic esophagitis(EoE). Here we present 3 children of various ages whose manifestations of EoE…”
Get full text

Feeding Disorders in Food Allergic Children by Haas, Angela M.

“…Feeding disorders are increasingly being recognized in children with food allergy. For some children, symptoms of feeding dysfunction may persist after…”
Get full text

Avian community composition, but not richness, differs between urban and exurban parks by Haas, Angela R, Kross, Sara M, Kneitel, Jamie M

“…Abstract Urban development alters landscape structure and available resources, potentially threatening avian diversity worldwide. However, it is unclear how…”
Get full text

Clinical Presentation of Feeding Dysfunction in Children with Eosinophilic Gastrointestinal Disease by Haas, Angela M., MA, CCC-SLP, Maune, Nancy Creskoff, OTR

“…Feeding issues may affect many aspects of a child's health, development, growth, nutrition and overall well-being. There is a developmental continuum for the…”
Get full text

Feeding Disorders in Food Allergic Children by Haas, Angela M.

Get full text

Fatal and non-fatal food injuries among children (aged 0–14 years) by Altkorn, Robert, Chen, Xiao, Milkovich, Scott, Stool, Daniel, Rider, Gene, Bailey, C. Martin, Haas, Angela, Riding, Keith H, Pransky, Seth M, Reilly, James S

“…Summary Objective To identify and characterize food items with high risk of airway obstruction in children younger than 15 years. Methods This retrospective…”
Get full text

Sean M. Quinlan, Morbid Undercurrents: Medical Subcultures in Post-revolutionary France by Haas, Angela C

Get full text

GLPG1205 for idiopathic pulmonary fibrosis: a phase 2 randomised placebo-controlled trial by Strambu, Irina R, Seemayer, Christian A, Fagard, Liesbeth M-C A, Ford, Paul A, Van der Aa, Tom A K, de Haas-Amatsaleh, Angela A, Modgill, Vikas, Santermans, Eva, Sondag, Eric N, Helmer, Eric G, Maher, Toby M, Costabel, Ulrich, Cottin, Vincent

“…GLPG1205 is a selective functional antagonist of G-protein-coupled receptor 84, which plays an important role in fibrotic processes. This study assessed the…”
Get full text

Opportunities for Innovation and Improved Care Using Telehealth for Nutritional Interventions by Knotowicz, Holly, Haas, Angela, Coe, Stephanie, Furuta, Glenn T., Mehta, Pooja

Get full text

Su1565: EFFICACY AND SAFETY OF FILGOTINIB IN PATIENTS WITH ULCERATIVE COLITIS STRATIFIED BY AGE: POST HOC ANALYSIS OF THE PHASE 2B/3 SELECTION AND SELECTIONLTE STUDIES by Schreiber, Stefan, Loftus, Edward V., Maaser, Christian, Danese, Silvio, Rudolph, Christine, Jongen, Rob, Haas, Angela de, Oortwijn, Alessandra, Vermeire, Séverine

Get full text

Tu1462: RE-TREATMENT WITH FILGOTINIB IN PATIENTS WITH ULCERATIVE COLITIS FOLLOWING TREATMENT INTERRUPTION: ANALYSIS OF THE SELECTION AND SELECTIONLTE STUDIES by Vermeire, Séverine, Feagan, Brian G., Peyrin-Biroulet, Laurent, Oortwijn, Alessandra, Faes, Margaux, Haas, Angela de, Rogler, Gerhard

Get full text

Long‐term safety and efficacy of filgotinib for the treatment of moderately to severely active ulcerative colitis: Interim analysis from up to 4years of follow‐up in the SELECTION open‐label long‐term extension study by Feagan, Brian G, Matsuoka, Katsuyoshi, Rogler, Gerhard, Laharie, David, Vermeire, Séverine, Danese, Silvio, Loftus, Edward V, Beales, Ian, Schreiber, Stefan, Hyo Jong Kim, Faes, Margaux, de Haas, Angela, Masior, Tomasz, Rudolph, Christine, Laurent Peyrin‐Biroulet

“…BackgroundFilgotinib, an oral, once‐daily, Janus kinase 1 preferential inhibitor, is an approved treatment for moderately to severely active ulcerative…”
Get full text

Introduction by the Guest Editors by Haas, Angela, Rhodes, Jackie, DeVoss, Dànielle Nicole

Get full text

Integrated safety analysis of filgotinib for ulcerative colitis: Results from SELECTION and SELECTIONLTE by Schreiber, Stefan, Rogler, Gerhard, Watanabe, Mamoru, Vermeire, Séverine, Maaser, Christian, Danese, Silvio, Faes, Margaux, Van Hoek, Paul, Hsieh, Jeremy, Moerch, Ulrik, Zhou, Yan, de Haas, Angela, Rudolph, Christine, Oortwijn, Alessandra, Loftus, Jr, Edward V

“…Filgotinib 200 mg (FIL200) is an approved treatment for adults with moderately to severely active ulcerative colitis (UC). To report integrated safety data…”
Get full text